One of the primary areas of focus in the Koch Institute is the development of new materials systems and biomedical devices for cancer prevention, detection and treatment. These systems underpin development of new approaches for biomarker detection, imaging modalities, and targeted therapies and vaccines. Center Members are exploring a wide range of materials to achieve these goals, and employ combinatorial development approaches to facilitate the discovery of new biomaterials and nanoformulations. State-of-the-art capabilities for high resolution and surface imaging and chemical and physical analysis are key tools to enable these studies. To fully characterize new materials, establish structure-property-function relationships, and facilitate subsequent rational design, we established the Nanotechnology Materials Core in 2012. In the previous competing renewal, the Core was approved for CCSG funding as an established Shared Resource. This Core integrates a range of advanced technologies including a state-of-the-art cryo-electron microscopy (cryo-EM) imaging suite, which enables high resolution analyses of soft biomaterials and cellular ultrastructure. In the current funding period, the Core added a significant number of new capabilities and modified existing services, including: new EM sample preparation instruments; new EM and correlative light and EM imaging systems; new physical/chemical characterization capabilities; and upgrades to existing instruments. To best capitalize on these acquisitions, CCSG Developmental funds were used to support two Cryo-EM Specialists. Core service usage by Center Members has increased, from 14% at the time of the last renewal to 43% of Center Members, who account for 79% of Core service use and include investigators from all three Research Programs. Core staff has established cryo-EM workflows that are customized for Center Member research needs, and we seek continued, partial funding to support and stabilize the Research Specialists? efforts. In the upcoming period, the Nanotechnology Materials Core will continue to offer a wide range of state-of-the- art services to support Center Member research programs, and will evaluate emerging capabilities in the context of Center Member needs and interests. A primary focus will be on refining new workflows to take full advantage of newly acquired instrumentation. Other planned initiatives include: developing resources to support advanced image processing, visualization, quantitation and machine learning, and collaborating with other Cores to develop a monthly workshop series to support Center Members? access to imaging technology platforms and data analysis. This Shared Resource is essential to the success of the Koch Institute mission and provides exceptional value to the CCSG. The requested CCSG budget for Year 49 is decreased by 40.6% over the Core CCSG budget for the current period (Year 48), reflecting the increased fraction of support from user chargebacks as Core staff is moved from CCSG Developmental funds to CCSG Core funds.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014051-49
Application #
9937095
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
49
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Guen, Vincent J; Edvardson, Simon; Fraenkel, Nitay D et al. (2018) A homozygous deleterious CDK10 mutation in a patient with agenesis of corpus callosum, retinopathy, and deafness. Am J Med Genet A 176:92-98
Murphy, Patrick A; Butty, Vincent L; Boutz, Paul L et al. (2018) Alternative RNA splicing in the endothelium mediated in part by Rbfox2 regulates the arterial response to low flow. Elife 7:
Khan, Omar F; Kowalski, Piotr S; Doloff, Joshua C et al. (2018) Endothelial siRNA delivery in nonhuman primates using ionizable low-molecular weight polymeric nanoparticles. Sci Adv 4:eaar8409
Woolston, Benjamin M; Roth, Timothy; Kohale, Ishwar et al. (2018) Development of a formaldehyde biosensor with application to synthetic methylotrophy. Biotechnol Bioeng 115:206-215
Huang, Hsin-Ho; Qian, Yili; Del Vecchio, Domitilla (2018) A quasi-integral controller for adaptation of genetic modules to variable ribosome demand. Nat Commun 9:5415
GuimarĂ£es, Pedro P G; Gaglione, Stephanie; Sewastianik, Tomasz et al. (2018) Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy. ACS Nano 12:912-931
Moynihan, Kelly D; Holden, Rebecca L; Mehta, Naveen K et al. (2018) Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability. Cancer Immunol Res 6:1025-1038
Nath, Samir R; Yu, Zhigang; Gipson, Theresa A et al. (2018) Androgen receptor polyglutamine expansion drives age-dependent quality control defects and muscle dysfunction. J Clin Invest 128:3630-3641
Kimmerling, Robert J; Prakadan, Sanjay M; Gupta, Alejandro J et al. (2018) Linking single-cell measurements of mass, growth rate, and gene expression. Genome Biol 19:207
Rothenberg, Daniel A; Taliaferro, J Matthew; Huber, Sabrina M et al. (2018) A Proteomics Approach to Profiling the Temporal Translational Response to Stress and Growth. iScience 9:367-381

Showing the most recent 10 out of 904 publications